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Prevention of syphilis: another positive beneﬁ t of male 
circumcision
Although rates of syphilis in the USA and Europe have 
increased slightly in the past decade, the greatest 
burden of syphilis lies in sub-Saharan Africa and Asia, 
where nearly 10 million cases occur every year, and more 
than 36 million people globally harbour the disease.1 
Recent studies have estimated that more than 5% of 
pregnant women in sub-Saharan Africa are infected 
with the spirochaete bacterium, Treponema pallidum, 
which causes syphilis.2 T pallidum is mainly spread 
by sexual contact and disease begins with a painless 
genital ulcer. However, if untreated, it can cause 
inﬂ uenza-like symptoms, a diﬀ use maculopapular rash, 
meningoencephalitis, tabes dorsalis, cardiovascular 
syphilis, and gummatous disease. In pregnancy, 
untreated early syphilis results in a stillbirth rate of 25% 
and is responsible for 14% of neonatal deaths, with an 
overall perinatal mortality of 40%.2
More than 40 observational studies and three 
randomised trials have shown that male circumcision 
reduces HIV acquisition in men by 50–60%, and 
long-term follow-up studies show even higher 
eﬃ  cacy of male circumcision.3,4 The randomised trials 
also showed that male circumcision decreases the 
risk of men acquiring genital ulcer disease, herpes 
simplex virus type 2, and oncogenic high-risk human 
papillomavirus.3–5 Additionally, male circumcision 
has direct beneﬁ ts for female partners with reduced 
transmission rates of high-risk human papillomavirus, 
bacterial vaginosis, and trichomoniasis.3,4
Although the data showing male circumcision 
reduces viral sexually transmitted infections (STIs) in 
men are clear, observational studies and randomised 
trials have had conﬂ icting results about bacterial STIs. 
Some observational studies have shown that male 
circumcision reduces syphilis, but others have found no 
association.3 A meta-analysis of 13 observational studies 
estimated that male circumcision signiﬁ cantly decreased 
syphilis by 33%.6 However, the two randomised trials 
that assessed T pallidum incidence in Rakai, Uganda 
(adjusted hazard ratio 1·10, 95% CI 0·75–1·65)5 and 
Kisumu, Kenya (risk ratio 1·23, 95% CI 0·41–3·65)7 
showed that male circumcision had no eﬀ ect on 
acquisition of syphilis.
In The Lancet Global Health, Jillian Pintye and 
colleagues8 from the Partners PrEP study team present 
one of the largest and most comprehensive analyses 
of syphilis incidence in men and women and the eﬀ ect 
of male circumcision. The investigators followed 4716 
HIV-1 serodiscordant couples, of whom roughly 50% of 
the men were circumcised. During follow-up (median 
time of 2·75 years), they noted that male circumcision 
signiﬁ cantly decreased incident syphilis by 42% in 
men compared with uncircumcised men, and male 
circumcision was most protective for men with HIV 
with a reduction of 62%. They also showed that male 
circumcision reduced female partner syphilis incidence 
by 59%, with a 75% reduction in the women without 
HIV and a 48% reduction in women with HIV. Thus, 
in this large prospective cohort, male circumcision 
was strongly associated with reductions in syphilis 
acquisition in both men and their female partners.  
There could be several reasons for the discordance 
between the randomised trial data and the cohort study 
by Pintye and colleagues. The incidence of syphilis in the 
two trials was low, which restricted the power to detect 
a diﬀ erence. The two trials assessed T pallidum incidence 
in men, but did not know their exposure status. A 
strength of Pintye and colleagues’ study was that the 
investigators were able to measure syphilis acquisition 
in men with known exposures. Additionally, the study 
assessed syphilis in HIV-1 discordant couples, whereas 
the randomised trials only assessed HIV-1 negative men 
with few men being in discordant relationships.  
The pathophysiology of male circumcision to reduce 
viral and bacterial STIs is probably due both to anatomical 
and cellular factors.3 Male circumcision removes a warm, 
moist subpreputial cavity that is formed by the foreskin, 
likely reducing the survival of viruses and bacteria. 
Male circumcision also removes a thinly keratinised, 
vascular foreskin tissue that is stretched and exposed 
to vaginal ﬂ uids when the penis is erect. The foreskin 
tissue is also prone to microabrasions that might allow 
STIs to penetrate. In addition to anatomical factors, the 
foreskin mucosa contains a high density of CD4+ T cells, 
CD8+ T cells, and CD1a+ dendritic cells.9 These cellular 
and anatomical factors for the protective role of male 
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circumcision are supported by the ﬁ nding that risk of HIV 
is highest in men with the largest foreskin surface area.10
After the randomised trials showed that male 
circumcision reduces acquisition of HIV in men, in 2007 
WHO–UNAIDS recommended that male circumcision 
should be promoted and scaled up to curb heterosexual 
transmission of HIV.4 After these initial ﬁ ndings were 
released, the medical beneﬁ ts of male circumcision 
have only become stronger with additional protection 
shown against herpes simplex virus type 2, high-risk 
human papillomavirus, and now syphilis.4 These new 
data should squelch concerns that there are no medical 
beneﬁ ts of male circumcision, and should continue to 
support programmes that encourage neonatal male 
circumcision and adult male circumcision globally, 
especially in the 14 priority countries in eastern and 
southern sub-Saharan Africa with large HIV epidemics. 
These programmes will not only have a substantial 
e ﬀ ect by improving the health of men and their 
female partners, but also by reducing health-care costs 
associated with the long-term treatment of STIs.11
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